Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-23-235414
Filing Date
2023-09-14
Accepted
2023-09-14 17:28:25
Documents
9
Effectiveness Date
2023-09-14

Document Format Files

Seq Description Document Type Size
1 S-3ASR d513860ds3asr.htm S-3ASR 398298
2 EX-4.3 d513860dex43.htm EX-4.3 28849
3 EX-4.4 d513860dex44.htm EX-4.4 239161
4 EX-5.1 d513860dex51.htm EX-5.1 36769
5 EX-23.1 d513860dex231.htm EX-23.1 1753
6 EX-FILING FEES d513860dexfilingfees.htm EX-FILING FEES 37806
7 GRAPHIC g513860dsp104.jpg GRAPHIC 3116
8 GRAPHIC g513860dsp104a.jpg GRAPHIC 2913
9 GRAPHIC g513860g31f69.jpg GRAPHIC 69228
  Complete submission text file 0001193125-23-235414.txt   847884
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 501 BRISBANE CA 94005 650 484-0899
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-274521 | Film No.: 231255987
SIC: 2834 Pharmaceutical Preparations